Christopher Raymond
Stock Analyst at Raymond James
(3.12)
# 2,630
Out of 4,703 analysts
873
Total ratings
45%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Christopher Raymond
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALMS Alumis | Maintained: Buy | n/a | $10.35 | - | 3 | Sep 3, 2026 | |
| BHVN Biohaven | Maintained: Buy | $30 | $15.69 | +91.20% | 23 | Aug 26, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $39 | $28.32 | +37.74% | 1 | Aug 14, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $7.31 | - | 1 | Aug 10, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $105 | $66.97 | +56.79% | 87 | Aug 7, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $19 → $15 | $3.80 | +294.74% | 42 | Aug 7, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $25.13 | - | 8 | Jul 17, 2026 | |
| CLYM Climb Bio | Maintained: Buy | n/a | $15.05 | - | 3 | Jun 24, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $40 | $26.92 | +48.59% | 1 | Jun 16, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $723 → $870 | $852.03 | +2.11% | 114 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $34.57 | +73.56% | 20 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $4.78 | +423.01% | 2 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $5.95 | +689.92% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.64 | +130.50% | 6 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 → $123 | $116.28 | +5.78% | 5 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 → $29 | $14.06 | +106.26% | 11 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $442.84 | - | 78 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $3.90 | +489.74% | 14 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $533 → $401 | $556.75 | n/a | 26 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $6.18 | n/a | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $26.53 | n/a | 58 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $4 | $13.59 | n/a | 6 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $111.08 | n/a | 5 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $220 → $227 | $261.72 | n/a | 84 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $1.79 | n/a | 21 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $307 → $315 | $222.67 | n/a | 91 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $10.17 | n/a | 19 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 | $34.13 | n/a | 11 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.000001 | n/a | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $8 | $2.08 | n/a | 24 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $61.33 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.9803 | n/a | 22 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $1,055.37 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 | $67.23 | n/a | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.48 | n/a | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $2.10 | n/a | 5 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $27.80 | n/a | 1 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $6.36 | n/a | 6 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $30 | $10.29 | n/a | 5 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $1.36 | n/a | 20 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $49.42 | n/a | 12 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.14 | n/a | 4 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $37.49 | n/a | 1 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.94 | n/a | 6 | Aug 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $42 → $101 | - | n/a | 2 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0016 | n/a | 6 | Mar 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3 → $6 | $2.60 | n/a | 3 | Feb 29, 2012 |
Alumis
Sep 3, 2026
Maintained: Buy
Price Target: n/a
Current: $10.35
Upside: -
Biohaven
Aug 26, 2026
Maintained: Buy
Price Target: $30
Current: $15.69
Upside: +91.20%
SpyGlass Pharma
Aug 14, 2026
Initiated Coverage: Buy
Price Target: $39
Current: $28.32
Upside: +37.74%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.31
Upside: -
BioMarin Pharmaceutical
Aug 7, 2026
Maintained: Buy
Price Target: $105
Current: $66.97
Upside: +56.79%
Ardelyx
Aug 7, 2026
Maintained: Buy
Price Target: $19 → $15
Current: $3.80
Upside: +294.74%
Tyra Biosciences
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $25.13
Upside: -
Climb Bio
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $15.05
Upside: -
Aktis Oncology
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $26.92
Upside: +48.59%
Regeneron Pharmaceuticals
Jan 30, 2026
Maintained: Buy
Price Target: $723 → $870
Current: $852.03
Upside: +2.11%
Jan 26, 2026
Maintained: Buy
Price Target: $60
Current: $34.57
Upside: +73.56%
Jan 13, 2026
Maintained: Buy
Price Target: $25
Current: $4.78
Upside: +423.01%
Dec 2, 2025
Initiated Coverage: Buy
Price Target: $47
Current: $5.95
Upside: +689.92%
Nov 25, 2025
Maintained: Buy
Price Target: $13
Current: $5.64
Upside: +130.50%
Nov 14, 2025
Maintained: Buy
Price Target: $142 → $123
Current: $116.28
Upside: +5.78%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $26 → $29
Current: $14.06
Upside: +106.26%
Oct 10, 2025
Maintained: Hold
Price Target: n/a
Current: $442.84
Upside: -
Sep 16, 2025
Maintained: Buy
Price Target: $23
Current: $3.90
Upside: +489.74%
Sep 2, 2025
Initiated Coverage: Hold
Price Target: $533 → $401
Current: $556.75
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: $13
Current: $6.18
Upside: n/a
Feb 14, 2025
Maintained: Buy
Price Target: $140
Current: $26.53
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $4
Current: $13.59
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $42
Current: $111.08
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $220 → $227
Current: $261.72
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $75
Current: $1.79
Upside: n/a
Oct 30, 2024
Maintained: Buy
Price Target: $307 → $315
Current: $222.67
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $20
Current: $10.17
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $56
Current: $34.13
Upside: n/a
Sep 16, 2024
Rated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: $21 → $8
Current: $2.08
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $58
Current: $61.33
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $4
Current: $0.9803
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $600
Current: $1,055.37
Upside: n/a
Jul 24, 2023
Rated: Hold
Price Target: $22
Current: $67.23
Upside: n/a
Apr 25, 2023
Maintained: Buy
Price Target: $14
Current: $1.48
Upside: n/a
Nov 22, 2022
Maintained: Hold
Price Target: $28
Current: $2.10
Upside: n/a
Jul 25, 2022
Initiated Coverage: Buy
Price Target: $28
Current: $27.80
Upside: n/a
May 23, 2022
Maintained: Buy
Price Target: $3
Current: $6.36
Upside: n/a
May 18, 2022
Maintained: Hold
Price Target: $75 → $30
Current: $10.29
Upside: n/a
May 11, 2021
Maintained: Hold
Price Target: $7 → $6
Current: $1.36
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: $8
Current: $49.42
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: n/a
Current: $8.14
Upside: n/a
Apr 18, 2019
Maintained: Hold
Price Target: n/a
Current: $37.49
Upside: n/a
Aug 7, 2017
Rated: Hold
Price Target: n/a
Current: $3.94
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $42 → $101
Current: -
Upside: n/a
Mar 19, 2013
Maintained: Hold
Price Target: n/a
Current: $0.0016
Upside: n/a
Feb 29, 2012
Upgraded: Buy
Price Target: $3 → $6
Current: $2.60
Upside: n/a